Ekso bionics announces reverse stock split

San rafael, calif., may 19, 2025 (globe newswire) -- ekso bionics holdings, inc. (the “company”) (nasdaq: ekso), a leading developer of exoskeletons for medical and industrial use, today announced that it will effect a reverse stock split of shares of its common stock at a ratio of 1-for-15, effective as of may 27, 2025 at 12:01 a.m. pacific time. the company's common stock will open for trading on the nasdaq capital market on may 27, 2025 on a split-adjusted basis under the existing symbol “ekso”. the company's common stock will trade under a new cusip number 282644 400 upon the effectiveness of the reverse stock split.
EKSO Ratings Summary
EKSO Quant Ranking